Literature DB >> 29096854

Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background.

Anja Hofmann1, Coy Brunssen1, David M Poitz2, Heike Langbein1, Ruth H Strasser2, Thomas Henle3, Ursula Ravens4, Henning Morawietz5.   

Abstract

OBJECTIVE: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is the major receptor for oxidized LDL in endothelial cells. LOX-1 is highly expressed in atherosclerotic plaques. The impact of LOX-1 on development of endothelial dysfunction in large vessels in absence or presence of atherosclerosis-prone conditions has not been studied to date.
METHODS: Mice with endothelial cell-specific LOX-1 overexpression (bLOX-1tg) were analyzed. Wild-type (WT) mice served as controls. In addition, bLOX-1tg mice were crossed with LDL receptor knockout (Ldlr-/-) mice. All mice were fed a western-type diet (WD) or control diet (CD) for 20 weeks. Afterwards, endothelial function was analyzed ex vivo in thoracic aortas using a Mulvany myograph.
RESULTS: WD induced hypertriglyceridemia (bLOX-1tg: 1.6-fold; WT: 1.4-fold) and hypercholesterolemia (P < 0.0001) in bLOX-1tg and WT mice without HDL-elevation in bLOX-1tg mice. Gonadal fat pad weight was 1.7 and 1.2-fold increased on CD and WD in bLOX-1tg mice compared to WT. LOX-1 overexpression impaired endothelial function by 15-16% (P < 0.05) on CD and WD. Crossing bLOX-1tg mice into Ldlr-/- background strongly elevated total (∼6-fold) and LDL-cholesterol (∼9-fold) compared to WT and bLOX-1tg mice on WD. Endothelial function in response to WD was impaired in bLOX-1tg/Ldlr-/- mice (Effmax: 56.7 ± 23.0%) compared to WT (Effmax: 88.2 ± 15.8%, P < 0.001), bLOX-1tg (Effmax: 76.7 ± 12.9%, P < 0.05) and Ldlr-/- mice (Effmax: 70.1 ± 13.1%, P < 0.05). No differences between WT, bLOX-1tg and Ldlr-/- mice were detectable when comparing all genotypes.
CONCLUSION: Endothelial LOX-1 overexpression in an atherosclerosis-prone background impairs endothelial function, proving its importance in the development of atherosclerosis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dyslipidemia; Endothelial dysfunction; LOX-1; Reactive oxygen species

Mesh:

Substances:

Year:  2017        PMID: 29096854     DOI: 10.1016/j.atherosclerosissup.2017.05.020

Source DB:  PubMed          Journal:  Atheroscler Suppl        ISSN: 1567-5688            Impact factor:   3.235


  6 in total

1.  miR-185 silencing promotes the progression of atherosclerosis via targeting stromal interaction molecule 1.

Authors:  Ming Fang; Yanfei Li; Yingbiao Wu; Zhongping Ning; Xuejun Wang; Xinming Li
Journal:  Cell Cycle       Date:  2019-03-20       Impact factor: 4.534

Review 2.  Atherosclerosis: nexus of vascular dynamics and cellular cross talks.

Authors:  Divya Dasagrandhi; Anusuyadevi Muthuswamy; Jayachandran Kesavan Swaminathan
Journal:  Mol Cell Biochem       Date:  2021-11-29       Impact factor: 3.396

3.  Overexpression of alanine-glyoxylate aminotransferase 2 protects from asymmetric dimethylarginine-induced endothelial dysfunction and aortic remodeling.

Authors:  Roman N Rodionov; Natalia Jarzebska; Dmitrii Burdin; Vladimir Todorov; Jens Martens-Lobenhoffer; Anja Hofmann; Anne Kolouschek; Nada Cordasic; Johannes Jacobi; Elena Rubets; Henning Morawietz; John F O'Sullivan; Alexander G Markov; Stefan R Bornstein; Karl Hilgers; Renke Maas; Christian Pfluecke; YingJie Chen; Stefanie M Bode-Böger; Christian P M Hugo; Bernd Hohenstein; Norbert Weiss
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

4.  Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis.

Authors:  Xiaopeng Guo; Yishan Guo; Zhiwen Wang; Bingxin Cao; Chuansheng Zheng; Zhuanglin Zeng; Yumiao Wei
Journal:  Oxid Med Cell Longev       Date:  2022-03-29       Impact factor: 6.543

5.  Protective Role of Perivascular Adipose Tissue in Endothelial Dysfunction and Insulin-Induced Vasodilatation of Hypercholesterolemic LDL Receptor-Deficient Mice.

Authors:  Natali Baltieri; Daniele M Guizoni; Jamaira A Victorio; Ana P Davel
Journal:  Front Physiol       Date:  2018-03-19       Impact factor: 4.566

6.  Soluble LOX-1: A Novel Biomarker in Patients With Coronary Artery Disease, Stroke, and Acute Aortic Dissection?

Authors:  Anja Hofmann; Coy Brunssen; Steffen Wolk; Christian Reeps; Henning Morawietz
Journal:  J Am Heart Assoc       Date:  2020-01-04       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.